Prostate Cancer Clinical Trial

Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American Men

Summary

This behavioral clinical trial assesses the efficacy of a educational intervention to increase shared decision making about PSA-based screening for prostate cancer among African American males. Half of participants will receive a multimedia educational intervention, while the other half will receive usual care.

View Full Description

Full Description

The 2018 U.S. Preventive Services Task Force (USPSTF) final recommendation states that male patients and their providers engage in a shared-decision making process about the benefits and harms of PSA-based screening. As characterized by the USPSTF, these conversations are particularly important for African American men given increased ambiguity due to the lack of PSA-based research specific to this population and increased risk of prostate cancer mortality attributed to late stage at diagnosis and more aggressive prostate cancer phenotypes seen in African American men.

The goal of this randomized behavioral clinical trial is to advance the translation path of implementing the decision-making process in clinical encounters by evaluating the efficacy of an educational intervention for African American males to increase shared decision making about PSA-screening versus usual care. The intervention will use multimedia educational training materials to increase understanding of prostate cancer, PSA-based screening, and shared decision making among patients and their primary care providers (PCPs).

View Eligibility Criteria

Eligibility Criteria

Patient Inclusion Criteria:

Receiving care at the clinical sites
Identify as African American male
Ages 40-69 years old

Patient Exclusion Criteria:

Personal history of prostate cancer at the time of consent
Cognitive impairment that would interfere with participation in the study
Unable to complete any aspect of the intervention within the specified time limit

Study is for people with:

Prostate Cancer

Estimated Enrollment:

161

Study ID:

NCT03869216

Recruitment Status:

Completed

Sponsor:

Xavier University of Louisiana.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Tulane Medical Center
New Orleans Louisiana, 70112, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

161

Study ID:

NCT03869216

Recruitment Status:

Completed

Sponsor:


Xavier University of Louisiana.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.